GlassScriptPhysician profile
Gregory M Seelhoefer
NPI 1528224144
$1,266.43
in general payments reported to CMS, 2019-2025
15 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $162 · 2021: $212 · 2022: $27.03 · 2023: $49.42 · 2024: $210 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $480 · Education: $23.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.30 |
| Education | $23.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $342.07 | 2019-2022 | |
| Pacira Therapeutics, INC. | $229.30 | 2019-2021 | |
| Bioventus LLC | $156.12 | 2020-2025 | Durolane, Xcell |
| Amgen INC. | $155.09 | 2024 | Prolia, Evenity |
| Novo Nordisk INC | $122.08 | 2021 | |
| Boston Scientific Corporation | $39.02 | 2025 | Watchman Flx |
| Pacira Pharmaceuticals Incorporated | $35.38 | 2023 | Exparel, Iovera, Zilretta |
| Exact Sciences Corporation | $31.63 | 2024-2025 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $30.77 | 2025 | Auvelity |
| Abbott Laboratories | $29.46 | 2023-2025 | Proclaim |
| Sanofi-Aventis U.S. LLC | $28.63 | 2019 | |
| Dexcom, INC. | $21.74 | 2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $16.55 | 2025 | |
| Depuy Synthes Sales INC. | $15.64 | 2021 | |
| Si-Bone, INC. | $12.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Seelhoefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.